Skip to main content
Premium Trial:

Request an Annual Quote

Tecan, UgenTec to Launch Sample-to-Answer PCR Workflows

NEW YORK — Tecan said on Thursday that it has partnered with Belgian molecular diagnostics software developer UgenTec to combine their respective technologies for integrated sample-to-answer PCR workflows.

Under the terms of their deal, the companies will market Tecan's liquid handling and automation workstations in combination with UgenTec's FastFinder PCR analysis software to diagnostics laboratories. Tecan said that the combined offering will also form the basis of vitro diagnostics platforms developed through its Synergence original equipment manufacturer service.

Financial and other terms of the agreement were not disclosed.

Both companies have struck other partnerships in the past. About a year ago, Switzerland-based Tecan began working with Zymo Research to launch a viral DNA/RNA extraction product. Around that same time, UgenTec partnered with LGC Biosearch Technologies on a SARS-CoV-2 detection workflow.

 

 

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.